CN Patent

CN108883152A — 防止和治疗肺孢子虫感染的方法

Assigned to Nap Pharmaceutical Group Co ltd · Expires 2018-11-23 · 7y expired

What this patent protects

本公开涉及通过向受试者施用式(I)‑(III)中的任一个的化合物(例如，化合物1的盐或其中性形式)来预防性和治疗性治疗肺孢子虫感染(即，由耶氏肺孢子虫引起的感染)的方法。本公开还涉及抑制肺孢子虫属复制的方法。本公开的方法可用于免疫受损的受试者。

USPTO Abstract

本公开涉及通过向受试者施用式(I)‑(III)中的任一个的化合物(例如，化合物1的盐或其中性形式)来预防性和治疗性治疗肺孢子虫感染(即，由耶氏肺孢子虫引起的感染)的方法。本公开还涉及抑制肺孢子虫属复制的方法。本公开的方法可用于免疫受损的受试者。

Drugs covered by this patent

Patent Metadata

Patent number: CN108883152A
Jurisdiction: CN
Classification: —
Expires: 2018-11-23
Drug substance claim: No
Drug product claim: No
Assignee: Nap Pharmaceutical Group Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.